The association between FokI polymorphism of vitamin D receptor (VDR) and tuberculosis (TB) susceptibility has been investigated previously; however, the results were inconsistent and conflicting. In the present study, a meta-analysis was performed to assess the relationship between VDR FokI gene polymorphism and the risk of TB. Material and methods: Databases including PubMed and Embase were searched for genetic association studies of FokI polymorphism of vitamin D receptor (VDR) and TB. Data were extracted by two independent authors and the pooled odds ratio (OR) with 95% confidence interval (CI) was calculated to assess the strength of the association between VDR FokI gene polymorphism and TB risk. Meta-regression and subgroup analyses were performed to identify the source of heterogeneity. Results: Thirty-four studies with a total of 5669 cases and 6525 controls were reviewed in the present meta-analysis. A statistically significant correlation was found between VDR FokI gene polymorphism and increased TB risk in two comparison models: the homozygote model (ff vs. FF: OR = 1.37, 95% CI: 1.17-1.60; P heterogeneity = 0.001) and the recessive model (ff vs. Ff + FF: OR = 1.32, 95% CI: 1.14-1.52; P heterogeneity = 0.006). Meta-regression found no source contributing to heterogeneity. However, sub-group analyses revealed that there was a statistically increased TB risk in the East and Southeast Asian population. Conclusions: Synthesis of the available studies suggests that homozygosity for the FokI polymorphism of the VDR gene might be associated with an increased TB risk, especially in the East and Southeast Asian population. Additional well-designed, larger-scale epidemiological studies among different ethnicities are needed.
Introduction
Tuberculosis (TB) is one of the most important infectious diseases, with an estimated 9.0 million new cases and 1.5 million deaths worldwide in 2013, and more than half were in the South-East Asia and Western Pacific Regions [1] . It is suggested that the susceptibility to disease after infection with Mycobacterium tuberculosis is influenced by many risk factors, such as malnutrition, HIV infection, and environmental and host genetic factors [2] [3] [4] [5] . Host genetic factors implicated in human susceptibility Arch Med Sci 5, October / 2016 1119 to TB include NRAMP, HLA-DQB1, interleukin (IL) genes and the vitamin D receptor (VDR) [6] [7] [8] .
Vitamin D deficiency seems to be involved in susceptibility to TB and severity of the disease [9] , and 1,25-dihydroxyvitamin D 3 , the activated form of vitamin D, is a potent immune modulator. Expression and nuclear activation of the VDR are essential for these activities of vitamin D. The VDR gene is located on the long arm of chromosome 12, and several polymorphisms occur in the 5′ regulatory region, coding region and 3′ untranslated region (UTR) [10] . Among all the gene loci, the one most studied recently is FokI [11] [12] [13] [14] [15] , which can regulate the transcriptional activity of the gene [16] . FokI polymorphism in combination with low serum vitamin D 3 may attenuate VDR functions, which in turn is strongly associated with TB [11] . Several studies have tried to investigate the role of FokI gene polymorphism on susceptibility to TB, but they have not reached a consensus. To date, two analyses on the FokI polymorphism and TB risk across different ethnicities have been reported [17, 18] , but they failed to identify a significant association of FokI polymorphism in overall populations. In addition, more recent studies concerning the association between the polymorphism and TB risk in different populations have not included the two analyses [8, [12] [13] [14] [15] [19] [20] [21] [22] [23] [24] . Furthermore, several important factors which may bias the results were not clearly addressed, such as Hardy-Weinberg equilibrium (HWE). Thus, it is necessary to evaluate the true association of the VDR FokI gene polymorphism and the risk of TB. In the present study, we performed an updated meta-analysis to address these discrepancies and to explore the risk factors associated with TB.
Material and methods

Literature search strategy
We performed a literature search of the PubMed, Web of Science and Embase web databases with a combination of the key words ''VDR'' or "Vitamin D receptor"; "FokI", "rs10735810"; "polymorphism" AND "Tuberculosis'' up to January 2015. Furthermore, we evaluated potentially relevant genetic association studies by manual searching of references of relative articles and reviews. Search results were limited to human populations. No language restrictions were applied.
Inclusion and exclusion criteria
Published articles included in the current meta-analysis were selected according to the following criteria: (1) appraisal of the association between VDR FokI gene polymorphism and TB risk, (2) case-control study design, (3) with clearly described and confirmed TB patients and TBfree controls, (4) containing available genotype frequency in cases and controls. The major reasons for study exclusion were data overlapping, case-only studies, reviews, repeated literature, and without genotype frequencies.
Data extraction and quality assessment
Data of each retrieved publication were independently abstracted in duplicate by two independent investigators with a standard procedure. Data extracted from the retrieved publications included the name of the first author, publication year, the country of origin, ethnicity, source of controls, number of cases and controls, study type, diagnosis method of cases, the selection of controls and genotype frequencies. The Hardy-Weinberg equilibrium (HWE) was examined by c 2 test (p < 0.05 was considered as significant disequilibrium) based on FokI genotyping distribution in controls.
Statistical analysis
Data from the meta-analysis were analyzed using STATA software (Version 12.1; Stata Corp, College Station, Texas, USA). The significance of the association for five comparison models -allele model (f vs. F), homozygote model (ff vs. FF), heterozygote model (Ff vs. FF), dominant model (ff + Ff vs. FF) and recessive model (ff vs. Ff + FF) -was evaluated for 34 studies separately. All associations were evaluated by calculating odds ratios (ORs) with the 95% confidence interval (CI). The statistical heterogeneity between studies was checked using the c 2 -based Q test and considered significant at p < 0.05. When there was no significant heterogeneity, the fixed effects model (Mantel-Haenszel method) was used; otherwise, the random-effects model (the DerSimonian and Laird method) was used. Sensitivity analyses were performed to identify an individual study's effect on pooled results and test the reliability of results. Meta-regression analysis was performed to explore the source of potential heterogeneity. Stratification analyses were performed to further identify the possible source of heterogeneity among variables, such as ethnicity and sample size (studies with more than 500 participants were defined as ''large'', and studies with less than 500 participants were defined as ''small''). Publication bias was assessed with both Egger's test and Begg's funnel plot, and the statistical significance was defined as p < 0.05. All p values were two-sided.
Results
Characteristics of enrolled studies
A flow chart of the study selection process is shown in Figure 1 . According to the inclusion crite-ria, 34 qualified case-control studies were selected in the final analysis after the literature search from the PubMed (Medline), Web of Science and Embase web databases [8, [10] [11] [12] [13] [14] [15] . Twenty-four studies were based on Asian populations [8, [10] [11] [12] [13] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] , seven were based on African populations [14, 15, [38] [39] [40] [41] [42] and the remaining three were conducted in Europe and America [43] [44] [45] . The eligible studies contained 4 "large" studies [19, 29, 40, 42] and 30 "small" studies [8, 10-15, 21-28, 30-39] . Thirty studies were genotyped by restriction fragment length polymorphism (RFLP) analysis and five were conducted by other methods [19, 23, 38, 40, 41] . The detailed characteristics of the enrolled studies are listed in Table I . A total of 5669 TB cases were obtained in the 34 studies, including 5126 (92.3%) with pulmonary TB and 426 (7.7%) with extra-pulmonary TB. The corresponding controls for the TB cases numbered 6525. Distribution of genotypes and HWE p-values in the controls are shown in Table II . Among the controls, the genotype distribution for 31 studies of the assessed polymorphisms was in HWE, except for 3 studies from India and Iran [31, 32, 35] .
Sensitivity analyses and publication bias
In the sensitivity analysis, the influence of each individual data set on the pooled OR was assessed by deleting one single study each time. The results showed that the corresponding pooled ORs were not materially varied, suggesting stability of this meta-analysis (data not shown). Begg's funnel plot and Egger's test were used to evaluate the publication bias of the selected studies for the meta-analysis (Figure 2 ). Begg's funnel plot seemed symmetrical in all genetic models. Furthermore, the statistical results from Egger's test supported the result of Begg's funnel plot indicating that there was no publication bias among all genetic models (p > 0.05) ( Table III) .
Meta-analysis results
We pooled all 34 studies together for the assessment of the relationship between the VDR FokI polymorphism and the risk of TB. The pooled ORs from overall studies indicated a significantly increased risk of TB in the homozygote model (ff vs. FF: OR = 1.37, 95% CI: 1.17-1.60; P heterogeneity = 0.001, Figure 3 ) and recessive model (ff vs. Ff + FF: OR = 1.32, 95% CI: 1.14-1.52; P heterogeneity = 0.006, Figure 4 ). However, no significant association was found in the allele model (f vs. F: OR = 1.09, 95% CI: 0.97-1.21; P heterogeneity = 0.000, Figure 5 ) and in the dominant model (ff + Ff vs. FF: OR = 1.08, 95% CI: 0.99-1.17; P heterogeneity = 0.000, Figure 6 ). The heterozygote model (Ff vs. FF: OR = 1.03, 95% CI: 0.95-1.13; P heterogeneity = 0.001, Figure 7 ) failed to show any association with the risk of TB. The strength of the association between VDR FokI gene polymorphism and TB risk is shown in Table IV .
To account for the sources of heterogeneity, we performed meta-regression by publication years, ethnicity, sample size, genotyping methods, as well as source of controls and type of TB. However, no significant source was found to substantially contribute to heterogeneity (Table V) .
To further investigate the heterogeneity, we performed subgroup analyses (Table IV) . To evaluate the possible effect of the geographical differences on the variability of overall estimates, we classified the studies conducted in Asia into two groups: East and Southeast Asia (China, Indonesian and South Korean) and South and West Asia (India and Iran). As a result, the enrolled studies were divided into five subgroups including Africans, East and Southeast Asians, South and West contacts-based studies, and importantly the association in healthy persons-based studies was reinforced in the allele model (f vs. F: OR = 1.13, 95% CI: 1.01-1.27; P heterogeneity = 0.001), the homozygote model (ff vs. FF: OR = 1.42, 95% CI: 1.18-1.70; P heterogeneity = 0.019) and the recessive model (ff vs. Ff + FF: OR = 1.31, 95% CI: 1.10-1.56; P heterogeneity = 0.028), which conferred a significantly increased risk of TB, whereas this risk was reversed in patient contacts-based studies with no significance in each model (Table IV) . In addition, when categorized by the sample size with a cutoff of 500 individuals, 30 out of 34 studies had sample sizes less than 500 and conferred an increased risk of TB for two comparison models: the homozygote model (ff vs. FF: OR = 1.38, 95% CI: 1.15-1.64; P heterogeneity = 0.002) and the recessive model (ff vs. Ff + FF: OR = 1.33, 95% CI: 1.14-1.56; P heterogeneity = 0.012). For the subgroup analysis by the genotyping methods, the homozygote model (ff vs. FF: OR = 1.47, 95% CI: 1.23-1.75; P heterogeneity = 0.001), recessive genetic model (ff vs. Ff + FF: OR = 1.39, 95% CI: 1.19-1.63; P heterogeneity = 0.010) and dominant model (ff + Ff vs. FF: OR = 1.10, 95% CI: 1.00-1.20; P heterogeneity = 0.000) remained statistically significant in PCR-RFLP studies (Table IV) .
Discussion
Tuberculosis is one of the leading causes of morbidity and mortality, and the VDR gene might be important in modulating host susceptibility to TB because of the potential roles of VDR in the immune response to TB. However, many studies generated conflicting association data concerning the association between VDR FokI gene polymorphism and the risk of TB.
Our present meta-analysis, based on 34 eligible studies until January 2015, provides evidence to propose a consistent effect of VDR FokI polymorphism. We found that the f allele was associated with a significantly increased risk of TB in the homozygote model (ff vs. FF) and the recessive model (ff vs. Ff + FF), especially in the East and Southeast Asian population. However, an insignificant association was found in South and West Asians, Africans, Americans and Europeans for all comparison models. To a certain extent, this finding could reflect the existence of racial differences, suggesting that this polymorphism might have a multifunctional role in the pathogenesis of TB or interact with other genetic and environmental factors. Previous studies including the WHO TB report suggested that the yellow race was more susceptible to TB than the black and white race [1] . Additionally, it was reported that the f allele frequency was higher in Asians than Africans [17] . Thus, the finding of this meta-analysis might be attributed to the racial differences. There are some limitations to this systematic review. First, some individual information such as age, sex, HIV status and environmental factors could not be obtained, which makes the detailed sub-grouping analyses and interpretation of the results difficult. Second, considering that diabetes, hypertension and any other medical problem may affect vitamin D level, the confounding effect should be taken into account. VDR FokI polymorphisms have been suggested to be related to diabetes in Asians [46] . Diabetes status in the study population may therefore influence the association observed for VDR polymorphisms and TB incidence. Therefore, the stratification of diabetes status would further reveal the relationship between VDR gene SNPs and TB. However, diabetes status was not reported in two-thirds of the enrolled studies. Therefore, it was not possible to apply stratification according to diabetes status. Third, the small sample sizes in some subgroup analyses may not comprehensively represent the population. More studies are needed to confirm the association of FokI polymorphisms and TB risk, especially in different ethnic populations. Fourth, the different experimental designs and diagnostic standards make the analyses prone to bias. Fifth, included studies were restricted to those published in English or Chinese in our study, which might introduce potential bias into data analysis as well. Sixth, based on the data provided by the articles and our own calculations, significant deviations from HWE (p < 0.05) in controls were observed for three studies based on Asians [31, 32, 35] . Thus, their results should be interpreted with more caution. We therefore repeated the meta-analyses after exclusion of these studies. However, this exclusion did not materially affect the results (Table VI) . Although genome-wide association studies (GWAS) are important for the discovery of genetic variations, we did not identify any published GWAS on this subject. In conclusion, the results from this meta-analysis demonstrate that VDR FokI polymorphism is associated with increased TB risk, especially in East and Southeast Asians, which supports the hypothesis that VDR might play an important role in the host defense against TB. However, due to the moderate strength of the associations, their values to be used for risk prediction should be considered cautiously, and future large scale case-control studies are required to validate these findings. Arch Med Sci 5, October / 2016 
